Table 3.
Comparison of clinical characteristics between hospitalized and non-hospitalized COVID-19 patients at inclusion*
| Baseline characteristics | All patients (N = 225) | Non-hospitalized patients (N = 170) | Hospitalized patients (N = 55) | t-value/ χ2- value | P |
|---|---|---|---|---|---|
| Age, years, median (min, max) |
62 (24, 94) |
58 (24, 94) |
68 (43, 92) |
4.039 |
<0.001 |
| Men (%) |
55.1 |
54.1 |
58.2 |
0.277 |
0.598 |
| Arterial hypertension (%) |
53.3 |
48.2 |
69.1 |
7.262 |
0.007 |
| Type-2 diabetes (%) |
16.9 |
12.9 |
29.1 |
7.721 |
0.005 |
| Dyslipidemia (%) |
19.6 |
16.5 |
29.1 |
4.207 |
0.040 |
| Cardio-vascular disease (%) |
17.8 |
15.3 |
25.5 |
2.935 |
0.087 |
| Chronic obstructive pulmonary disease (%) |
6.2 |
5.3 |
9.1 |
1.027 |
0.311 |
| Asthma (%) |
5.3 |
4.7 |
7.3 |
0.542 |
0.461 |
| Chronic kidney disease (%) |
15.1 |
12.4 |
23.6 |
4.124 |
0.042 |
| Previous deep vein thrombosis/pulmonary embolism (%) |
3.1 |
1.8 |
7.3 |
4.182 |
0.041 |
| Body mass index, kg/m2, mean ± standard deviation | 29.8 ± 5.4 | 29.2 ± 5.1 | 31.0 ± 5.4 | 1.825 | 0.070 |